Annals of Cardiac Anaesthesia · 2016 · 19 citations · 9 references
MedicineNephrologySurgeryKidney TransplantationPulmonologyTransplant SurgeryBreathing SupportExtracorporeal Life SupportExtracorporeal Membrane OxygenationLung TransplantationMechanical VentilationVentilatory SupportDouble-lumen Endobronchial TubeGas Exchange AbnormalitiesPulmonary Supportive CareRenal Dysfunction After TransplantRenal Transplant CareRenal Transplant SurgeryRespiratory Gas ExchangeTreatment Modality Selection
Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by accumulation of excessive lung surfactant in the alveoli leading to restrictive lung functions and impaired gas exchange. Whole lung lavage (WLL) is the treatment modality of choice, which is usually performed using double lumen endobronchial tube insertion under general anesthesia and alternating unilateral lung ventilation and washing with normal saline. It may be difficult to perform WLL in patients with severe hypoxemia wherein patients do not tolerate single lung ventilation. Extracorporeal membrane oxygenation support (ECMO) has been used in such patients. We report a patient with autoimmune PAP following renal transplant who presented with marked hypoxemia and was managed by WLL under ECMO support.
9
Pulmonary Alveolar Proteinosis
Samuel H. Rosen, Benjamin Castleman, Averill A. Liebow et al. · New England Journal of Medicine · 1958 · 1.2K citations
Pulmonary Alveolar Proteinosis
José Ramírez-R · Archives of Internal Medicine · 1963 · 148 citations
Rituximab therapy in autoimmune pulmonary alveolar proteinosis
Raphaël Borie, M. P. Debray, Christine Lainé et al. · European Respiratory Journal · 2009 · 105 citations